Skip to main content
Clinical Trials/JPRN-UMIN000020112
JPRN-UMIN000020112
Completed
未知

Evaluation of plasma arginine vasopressin in hypertonic saline test in patients with diencephalohypophysial diseases - Evaluation of plasma arginine vasopressin in hypertonic saline test in patients with diencephalohypophysial diseases

Department of Endocrinology and Diabetes, Nagoya Graduate School of Medicine0 sites20 target enrollmentDecember 8, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes insipidus
Sponsor
Department of Endocrinology and Diabetes, Nagoya Graduate School of Medicine
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2015
End Date
June 10, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Endocrinology and Diabetes, Nagoya Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients suspected of having diabetes insipidus (Serum Na concentration is not less than 147 mEq/L and daily urine volume is not less that 2000 mL)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of arginine-stimulating test for diagnosis of central diabetes insipidus
JPRN-jRCTs041220082Arima Hiroshi50
Active, not recruiting
Phase 1
Arginin Vasopressin im fortgeschrittenen vasodilatorischen Schock: Ein Dosisvergleich 2 vs. 4 IU/h5. Einschlusskriterien5.1. Patienten mit vasodilatorischem Schock aufgrund:a) Sepsis [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]b) SIRS [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]c) SIRS nach herzchirurgischen Eingriffen mit Verwendung der Herzlungen-Maschine5.2. Hypotonie (MAP <60 mmHg) trotz5.3. Noradrenalinbedarf >0,6 µg/kg/min zur Erreichung eines MAP >60 mmHgMedDRA version: 9.1Level: LLTClassification code 10021118Term: Hypotonia
EUCTR2007-005010-40-ATniv.-Prof. Dr. Volker Wenzel50
Completed
Not Applicable
Perioperative response of arginine vasopressin and aquaporin-2 in cardiac surgeryheart disease required cardiac surgery
JPRN-UMIN000036594ippon Medical School8
Recruiting
Not Applicable
Registry of Patients in Shock Treated With VasopressinVasopressin Causing Adverse Effects in Therapeutic UseShockVasopressor Adverse ReactionVasopressin Deficiency
NCT06422975Hospital Universitario 12 de Octubre500
Active, not recruiting
Phase 1
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR TrialAcute Kidney Injury, Liver transplantationMedDRA version: 21.0Level: LLTClassification code: 10024716Term: Liver transplantation Class: 10042613MedDRA version: 21.1Level: LLTClassification code: 10000821Term: Acute kidney failure Class: 10038359Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
CTIS2023-506512-40-00Assistance Publique Hopitaux De Paris304